Enorama Pharma AB (publ) (STO:ERMA)
Sweden · Delayed Price · Currency is SEK 1.240
+0.848 (216.33%)
Aug 14, 2026, 5:29 PM CET
Enorama Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -65.27 | -75.14 | -43.81 | -44.61 | -42.03 | -27.74 |
Depreciation & Amortization | 0.08 | 0.13 | 0.44 | 0.68 | 0.67 | 0.66 |
Other Amortization | 0.34 | 0.34 | 2.87 | 2.87 | 2.87 | 0.72 |
Asset Writedown & Restructuring Costs | - | - | 17.1 | - | - | - |
Other Operating Activities | 18.93 | 16.57 | - | - | - | - |
Change in Accounts Receivable | 13.48 | -1.41 | 0.72 | 2.26 | 4.2 | -2.6 |
Change in Inventory | -10.58 | -6.12 | -6.98 | -1.46 | -1.6 | 0.48 |
Change in Other Net Operating Assets | -2.24 | 6.36 | -6.04 | -1.09 | 2.94 | -1.68 |
Operating Cash Flow | -45.27 | -59.26 | -35.7 | -41.35 | -32.96 | -30.16 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | - | - | -0.06 |
Sale (Purchase) of Intangibles | - | - | - | - | - | -1.76 |
Investing Cash Flow | - | - | - | - | - | -1.82 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 20.13 | - | 2.2 | 20 | 8 |
Long-Term Debt Repaid | - | - | -0.44 | -3.46 | -2.09 | -9.92 |
Net Debt Issued (Repaid) | 36.18 | 20.13 | -0.44 | -1.26 | 17.91 | -1.92 |
Issuance of Common Stock | 18.49 | 31.17 | 40.4 | 43.13 | 9 | 43.21 |
Other Financing Activities | -0.02 | -0.61 | -4.68 | - | -1.57 | -1.79 |
Financing Cash Flow | 54.65 | 50.69 | 35.29 | 41.86 | 25.35 | 39.51 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 3.73 | 9.52 | -3.65 | 1.5 | -0.45 | -0.06 |
Net Cash Flow | 13.12 | 0.95 | -4.07 | 2.01 | -8.06 | 7.47 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -45.27 | -59.26 | -35.7 | -41.35 | -32.96 | -30.22 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2074.47% | -2163.60% | -226.42% | -3044.85% | -481.35% | -236.14% |
Free Cash Flow Per Share | -0.62 | -0.85 | -0.67 | -1.49 | -4.21 | -4.88 |
Levered Free Cash Flow | -8.06 | -7.35 | -34.96 | -23.22 | -19.52 | -27.22 |
Unlevered Free Cash Flow | -8.06 | -6.62 | -34.69 | -22.67 | -18.72 | -26.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 5.74 | 11.42 | 2.99 | 3.59 | 2.09 | 0.8 |
Change in Working Capital | 0.67 | -1.16 | -12.31 | -0.28 | 5.54 | -3.8 |